1[1]Appelmelk BJ,Faller G, Claeys D. et al. Bugs ontrial, the case of HelicobacterPylori and autoimmuity[J]. Immun. today. 1998, 19 (7): 296 299.
2[2]Appelmelk BJ, Simoons -Smit I, Negrini R, et al. Potential role of molecular minicry between Helicobacter pylori lipopolysaccharide and hostLewis blood group antigens in autoimmunity[J].Infect Immun. 1996,64(6): 2031 - 2040.
3[3]Atherton JC,Cover TL,Twells RJ,et al. Simpleand accurate PCR based system for typing vacuolating cytotoxin alleles of Helicobacter pylori[J ].JClin Micro- biol. 1999,37(9) :2979 - 2982.
4[4]Azuma T, I to S, Satoo F, et al. The role of HLADQA1 gene in resistance to atrophic gastritis andgastric adenocarcinoma induced by Helicobacter pylori infection[J ]. Cancer, 1998,82(4): 1013 - 1018.
5[5]Blaser MJ, Not all Helicobacter pylori strain are created equal:Should al lbe eliminate[J ]. Lancet,1997,349( 9057):1020- 1022.
6[6]Blaser MS, Perez- Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strain possessing cag A is associated with an increased risk of developing adeno-carcinoma of the stomach[J]. Cancer Research. 1995, 55 ( 11 ): 2111 - 2115.
7[7]Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori tohumangastr epithelium mediated by blood group antigens[J]. Science, 1993, 262(5141 ): 1892 - 1895.
8[8]Censini S, Lange C, Xiag Z, etal. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated vir ulence factors[J ]. Proc Natl Acad Sci USA.1996,93: 14648 - 14653.
9[9]Churin Y, Kardalinen E, Meyer TF, and Nau-mann M. Pathogenicity island dependent activation of Rho GTPases Rac 1 and Cdc 42 in Helicobacter pylori infection [J]. Mol Microbiol.2001,40(4) :815 - 823.
10[10]Correa P. and Miller MJS. Helicobacter pylori and gastric atroply - cancer para doxes [ J ]. J.Natl Canc Ist. 1995,87(23): 1731 - 1732.
